Why agilon health (AGL) Shares Are Falling Today

Recent Developments

Agilon Health (NYSE:AGL), a company specializing in healthcare services, experienced a sharp 13.5% decline in its stock price during the afternoon trading session. This drop followed the release of a disappointing February employment report, which revealed an unexpected decrease in overall jobs, including notable losses within the healthcare sector.

The latest data showed that the U.S. economy shed 92,000 nonfarm payroll positions, a significant downturn compared to the 50,000 job increase that analysts had forecasted. The healthcare industry, which usually sees steady employment growth, lost 28,000 jobs—an abrupt change from the gains seen the previous month. This negative trend has heightened worries among investors about a possible economic slowdown, potentially leading to decreased spending and demand for healthcare services. According to the Labor Department, recent strikes contributed to the reduction in healthcare hiring.

Market reactions to such news can sometimes be exaggerated, and steep price declines may create attractive entry points for investors seeking quality stocks. Is this a good moment to consider investing in Agilon Health?

Market Sentiment and Stock Performance

Agilon Health’s stock is known for its high volatility, having experienced 81 price swings exceeding 5% over the past year. However, the recent drop stands out even for this stock, signaling that the latest news has had a substantial effect on how investors view the company.

Just two days earlier, Agilon Health’s shares surged by 23.1% after Chief Markets Officer Benjamin Shaker acquired 500,000 shares of common stock, a transaction worth about $301,050. This purchase increased his stake by roughly 57.6%, bringing his total holdings to 1,367,674 shares. Such significant insider buying is often interpreted by the market as a strong vote of confidence in the company’s future, suggesting that leadership believes the shares are undervalued.

Since the start of the year, Agilon Health’s stock has fallen by 12.6%. Currently trading at $0.59 per share, it sits 89.6% below its 52-week high of $5.68 reached in April 2025. For context, an investor who put $1,000 into Agilon Health at its IPO in April 2021 would now see that investment reduced to just $19.00.

Spotlight: A New Opportunity?

WHILE YOU’RE HERE: The Next Palantir? There’s a satellite company capturing daily images of every location on the planet. The Pentagon is interested, and hedge funds are leveraging its data for an edge in earnings. Yet, it remains relatively unknown to the public.

This scenario mirrors the early days of Palantir before it evolved into a $437 billion powerhouse. The strategy is similar, though the technology differs. If you missed out on Palantir, this could be your chance to learn more.